Elevated serum S100B levels have been reported in individuals with major depressive disorder (MDD), bipolar disorder, and anxiety, often correlating with disease severity, glial dysfunction, and increased blood–brain barrier permeability [107]. This evidence concerns the gene S100B and major depressive disorder.